uk
coronaviru
cancer
monitor
project
ukccmp
aim
collect
analys
dissemin
real
time
data
uk
cancer
centr
sever
acut
respiratori
syndrom
coronaviru
infect
rate
patient
cancer
outcom
term
coronaviru
diseas
approach
enabl
oncologist
gain
crucial
insight
inform
decis
make
decemb
sever
case
acut
respiratori
syndrom
hubei
provinc
china
identifi
first
describ
case
caus
viru
new
strain
betacoronaviru
previous
identifi
human
thought
zoonot
origin
present
vari
minor
symptom
akin
common
cold
sever
acut
respiratori
distress
syndrom
result
sever
impair
respiratori
function
highli
contagi
direct
transfer
respiratori
droplet
cough
sneez
indirect
fomit
spread
via
contamin
surfac
simpl
transmiss
coupl
intern
travel
enabl
rapid
spread
viru
case
death
report
worldwid
april
approxim
million
individu
live
histori
cancer
uk
new
diagnos
day
patient
substanti
proport
requir
undergo
recov
surgeri
complex
treatment
patient
cancer
potenti
increas
suscept
infect
seriou
sequela
result
impair
immun
function
due
cancer
cancer
treatment
wenhua
liang
colleagu
report
identif
patient
cancer
cohort
patient
china
indic
increas
incid
patient
cancer
compar
gener
chines
popul
vs
observ
also
suggest
yu
colleagu
investig
infect
patient
cancer
tertiari
care
hospit
wuhan
incid
patient
cancer
patient
higher
gener
wuhan
popul
patient
specif
type
cancer
might
increas
risk
report
highlight
high
proport
patient
lung
cancer
confirm
diagnos
five
patient
liang
et
al
seven
yu
et
al
specif
cancer
treatment
might
also
differenti
contribut
risk
sever
infect
associ
cytokin
storm
increas
concentr
creactiv
protein
pneumon
sever
advers
event
also
associ
immun
checkpoint
inhibitor
therapi
consequ
patient
immunotherapi
could
increas
risk
furthermor
cytotox
treat
ment
use
haematolog
malign
diminish
lymphocyt
popul
potenti
render
patient
suscept
infect
convers
mani
cancer
treatment
solid
tumour
littl
effect
lymphocyt
popul
inflammatori
respons
therefor
infect
highli
unlik
affect
patient
cancer
equal
european
societi
medic
oncolog
publish
guidelin
mitig
effect
patient
cancer
prioritis
cancer
treatment
patient
expect
deriv
substanti
absolut
surviv
benefit
reduc
hospit
visit
convert
intraven
oral
regimen
howev
guidelin
take
broad
approach
heterogen
popul
polici
includ
selfisol
social
distanc
wide
acknowledg
requir
suppress
viral
spread
gener
atrisk
popul
therebi
reduc
pressur
alreadi
stretch
healthcar
resourc
howev
substanti
realloc
resourc
away
cancer
care
servic
could
potenti
unintend
cancerrel
implic
includ
increas
morbid
mortal
therefor
realtim
collect
analysi
dissemin
data
cancer
centr
infect
rate
patient
cancer
diseas
outcom
need
ukccmp
launch
march
aim
involv
uk
cancer
centr
achiev
goal
local
emerg
respons
report
group
creat
uk
cancer
centr
ensur
continu
updat
ukccmp
live
clinic
data
dissemin
system
project
collect
data
patient
cancer
posit
infect
includ
tumour
type
stage
patient
age
present
cancer
treatment
clinic
outcom
aim
enabl
oncologist
gain
crucial
insight
inform
decis
make
data
collect
analysi
dissemin
coordin
centr
comput
biolog
univers
birmingham
birmingham
uk
dedic
workflow
host
comput
storag
life
scienc
infrastructur
part
birmingham
environ
academ
research
local
cloud
ukccmp
deliv
meaning
realtim
data
uk
cancer
centr
clinician
allow
personalis
approach
individu
patient
care
inform
clinic
decis
make
initi
improv
cancer
care
uk
beyond
time
unpreced
global
turmoil
relianc
healthcar
resourc
declar
compet
interest
thank
oncologist
acut
physician
healthcar
staff
work
tirelessli
frontlin
pandem
uk
coronaviru
monitor
project
team
donat
time
resourc
support
project
project
initi
fund
donat
time
resourc
support
advoc
project
univers
birmingham
initi
process
provicechancellor
dedic
comput
human
resourc
univers
centr
comput
biolog
institut
translat
medicin
scientist
institut
cancer
genom
scienc
academ
institut
dedic
time
staff
project
includ
univers
oxford
univers
leed
univers
colleg
london
edinburgh
cancer
centr
clatterbridg
cancer
centr
king
colleg
london
member
uk
coronaviru
cancer
monitor
project
team
list
appendix
p
institut
cancer
genom
scienc
univers
birmingham
birmingham
uk
